Sen. John Boozman Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Senator John Boozman (R-Arkansas) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on May 14th, the Senator disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on April 16th.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Lam Research NASDAQ: LRCX on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/15/2025.
• Sold $1,001 - $15,000 in shares of Bank of America NYSE: BAC on 4/15/2025.
• Purchased $1,001 - $15,000 in shares of iShares iBoxx $ High Yield Corporate Bond ETF NYSEARCA: HYG on 4/9/2025.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $34.05 during trading on Thursday, hitting $273.96. The stock had a trading volume of 121,312,755 shares, compared to its average volume of 5,593,150. UnitedHealth Group Incorporated has a 1 year low of $249.12 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's 50 day moving average is $478.83 and its two-hundred day moving average is $517.83. The stock has a market cap of $248.52 billion, a price-to-earnings ratio of 17.67, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the firm earned $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 3.07%. UnitedHealth Group's payout ratio is 35.18%.

Institutional Investors Weigh In On UnitedHealth Group

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its holdings in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors increased its holdings in shares of UnitedHealth Group by 6.2% in the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $6,375,744,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Robert W. Baird reduced their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Barclays dropped their target price on shares of UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a report on Thursday. Finally, KeyCorp dropped their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a report on Wednesday. Six investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $508.38.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas' U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman's academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.